Delivery Order SPE2DR25D7059-SPE2DR26F7MHT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $7,446.61 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count packages) on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-transaction delivery under...
- The Defense Logistics Agency awarded a $4,788.94 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Xulane 150-35 mcg/day patches (three-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xulane is a contraceptive transdermal patch, representing a routine pharmaceutical procurement through the...
- The Defense Logistics Agency awarded a $1,299.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day patches (3-unit supply) on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,750.03 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package) on November 7, 2025, with completion expected by November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $3,862.46 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3 units) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,077.49 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on October 29, 2025, with completion scheduled for October 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $5,477.59 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $22,572.33 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. XULANE is a combination hormonal contraceptive patch used for birth...
- The Defense Logistics Agency awarded a delivery order valued at $10,623.13 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY patches (a three-pack contraceptive transdermal patch). This firm fixed price, competitively awarded delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement executed through the agency's established...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MHTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on November 26, 2025, with a ceiling value of $2,378.70 and completion date of November 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The transdermal contraceptive patch being procured under this delivery order represents one of many pharmaceutical products the company delivers through this strategic contract vehicle to serve federal healthcare beneficiaries, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/25/25 |